microchips' technology is based on proprietary reservoir arrays that are used to store and protect potent drugs within the body for long periods of time. These arrays are designed for compatibility with preprogrammed microprocessors, wireless telemetry, or sensor feedback loops to provide active control. Individual device reservoirs can be opened on demand or on a predetermined schedule to precisely control drug release or sensor activation.
Our reservoir-based platform can also be used in passive control systems without microprocessors or power sources. microchips' passive systems are designed to release or expose their contents based on the controlled degradation of polymeric matrices over time. These systems form the basis for miniature insertable devices that provide maximum flexibility for device placement.
Our intellectual property portfolio supports our platform technologies and commercial products in development with approximately 140 issued or pending patents. These patents range from microreservoir fabrication and control, to long-term implantable technologies and wireless communications, as well as protein and peptide formulations for challenging delivery conditions.